Marta Ruiz

Navarre Institute of Health Research — Spain

Immunology and Microbiology · Life Sciences

27h-index2.2kcitations74works9.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(28), Cancer Immunotherapy and Biomarkers(14), CAR-T cell therapy research(10), vaccines and immunoinformatics approaches(10), T-cell and B-cell Immunology(9)

Publications74 total

MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
OncoImmunology·2025· 3 citedOpen Access
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in mice
Hepatology·2024· 5 citedOpen Access
Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort
Science Advances·2024· 33 citedOpen Access
Konectom™ cognitive processing speed test enables reliable remote, unsupervised cognitive assessment in people with multiple sclerosis: Exploring the use of substitution time as a novel digital outcome measure
Multiple Sclerosis Journal·2024· 5 cited
Non-canonical ORFs are an important source of tumor-specific antigens in a liver cancer meta-cohort
Figshare·2024Open Access
Non-canonical ORFs are an important source of tumor-specific antigens in a liver cancer meta-cohort
2023· 2 citedOpen Access
Data from Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
2023Open Access
Data from Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
2023Open Access
Supplementary Figures 1-8, Table 1 from Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
2023Open Access
Supplementary Figures 1-8, Table 1 from Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
2023Open Access
Résultats finaux de TEC-ADHERE : étude non interventionnelle sur la persistance au diméthyl fumarate (DMF) des patients atteints de SEP-RR bénéficiant ou non d’un soutien dans le cadre du programme d’accompagnement OroSEP
Revue Neurologique·2023
Résultats finaux de l’étude LymphoTEC : données en vie réelle sur la reconstitution lymphocytaire chez des patients lymphopéniques traités par diméthylfumarate
Revue Neurologique·2023
Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
Frontiers in Immunology·2023Open Access
Proactive classical biological control of Lycorma delicatula (Hemiptera: Fulgoridae) in California (U.S.): Host range testing of Anastatus orientalis (Hymenoptera: Eupelmidae)
Frontiers in Insect Science·2023· 20 citedOpen Access
Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
Frontiers in Immunology·2023· 3 citedOpen Access
Non-canonical ORFs are an important source of neoantigens in patient tumors
Figshare·2023Open Access
HELCOM BLUES case study: Microplastic concentrations in marine bottom sediments of the German Baltic Sea
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
Frontiers in Immunology·2022· 17 citedOpen Access
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
Frontiers in Immunology·2022· 6 citedOpen Access
Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Français de la Sclérose en Plaques registry
Multiple Sclerosis Journal - Experimental Translational and Clinical·2022· 3 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Pablo Sarobe(27), Juan José Lasarte(22), Diana Llópiz(18), Leyre Silva(11), Jesús Prìeto(11), Noëlia Casares(10), Francisco Borrás‐Cuesta(8), Sandra Hervás‐Stubbs(8), Josune Egea(7), Emmanuel Roze(7), Aurélie Méneret(7), Belén Aparicio(7), David Repáraz(6), Lorea Villanueva(5), Bruno Sangro(5), Teresa Lozano(5), Nicole Déglon(4), Marie Vidailhet(4), Virginia Belsúe(4), Cristian Smerdou(3)